CATALYST PHARMACEUTICALS, INC. Insider Trading for November 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CATALYST PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CATALYST PHARMACEUTICALS, INC. for November 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17 2017 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | M | 0.47 | 50,000 | 23,500 | 145,000 | |
| Nov 17 2017 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | M | 0.47 | 50,000 | 23,500 | 513,376 | 463.4 K to 513.4 K (+10.79 %) |
| Nov 14 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | M | 0.00 | 26,667 | 0 | 0 | |
| Nov 14 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | M | 0.00 | 26,667 | 0 | 4,697,693 | 4.7 M to 4.7 M (+0.57 %) |
| Nov 13 2017 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | M | 0.47 | 50,000 | 23,500 | 145,000 | |
| Nov 13 2017 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Payment of Exercise | F | 0.00 | 7,860 | 0 | 215,427 | 223.3 K to 215.4 K (-3.52 %) |
| Nov 13 2017 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | M | 0.47 | 50,000 | 23,500 | 223,287 | 173.3 K to 223.3 K (+28.85 %) |
| Nov 13 2017 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | M | 0.47 | 50,000 | 23,500 | 145,000 | |
| Nov 13 2017 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Payment of Exercise | F | 0.00 | 7,860 | 0 | 305,541 | 313.4 K to 305.5 K (-2.51 %) |
| Nov 13 2017 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Buy | M | 0.47 | 50,000 | 23,500 | 313,401 | 263.4 K to 313.4 K (+18.98 %) |
| Nov 07 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | M | 0.47 | 200,000 | 94,000 | 500,000 | |
| Nov 07 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | M | 0.47 | 200,000 | 94,000 | 4,671,026 | 4.5 M to 4.7 M (+4.47 %) |
| Nov 07 2017 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | M | 0.47 | 200,000 | 94,000 | 285,000 | |
| Nov 07 2017 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Buy | M | 0.47 | 200,000 | 94,000 | 657,687 | 457.7 K to 657.7 K (+43.70 %) |
| Nov 07 2017 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Financial Off ... | Option Exercise | M | 0.47 | 200,000 | 94,000 | 270,000 | |
| Nov 07 2017 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Financial Off ... | Buy | M | 0.47 | 200,000 | 94,000 | 396,346 | 196.3 K to 396.3 K (+101.86 %) |